Search - tctmd.com

Displaying 341 - 360 of 675

Sort: Relevancy | Date

Presentation TCT 2021

Don't Trip on the Wires: Managing Pacemaker Leads During TTVR

Presenter: Neil P. Fam

November 04, 2021

Presentation TCT 2021

TCT 565: Left Atrial Intramural Hematoma

Presenter: Aditya Kesari

November 04, 2021

Presentation TCT 2021

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Presenter: David E. Kandzari

November 04, 2021

Presentation TCT 2021

Transcatheter Tricuspid Valve Replacement: Overview of Current Clinical State

Presenter: Molly Szerlip

November 04, 2021

Presentation TCT 2021

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

Presenter: Kristen Brown

November 04, 2021

News Conference News TCT 2021

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

Michael O'Riordan

November 04, 2021

Presentation TCT 2021

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

Presenter: Ahmed El Shaer

November 04, 2021

Presentation TCT 2021

CLASP

Presenter: Molly Szerlip

November 04, 2021

Presentation TCT 2021

Triluminate

Presenter: Paul Sorajja

November 04, 2021

Presentation TCT 2021

Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations

Presenter: Jason Rogers

November 04, 2021

Presentation TCT 2021

TCT 540: LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI

Presenter: Michael Chiang

November 04, 2021

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles J. Davidson

November 04, 2021

Presentation TCT 2021

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Presenter: Charles Davidson

November 04, 2021

Presentation TCT 2021

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Presenter: Michael A. Weber

November 04, 2021

Presentation TCT 2021

Triluminate Registry: Lessons Learned for TEER Trial Design

Presenter: Georg Nickenig

November 04, 2021

Presentation TCT 2021

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

Presenter: Mir Basir

November 04, 2021

Presentation TCT 2021

Imaging Optimization and Algorithm for Procedural Success

Presenter: Scott Chadderdon

November 04, 2021

Presentation TCT 2021

Introduction to case: Zero contrast PCI in the RCA for an ACS patient with MVD

Presenter: Allen Jeremias

November 04, 2021

Presentation TCT 2021

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

Presenter: Debbie Cohen

November 04, 2021

Presentation TCT 2021

Standardized Nomenclature for Leaflet Anatomy and Utility for Pre-procedural TEER Planning

Presenter: Philipp Lurz

November 04, 2021

Advertisement

Don't Trip on the Wires: Managing Pacemaker Leads During TTVR

TCT 565: Left Atrial Intramural Hematoma

The SPYRAL Clinical Trials Program (Radiofrequency Renal Denervation): Clinical Trials Status Update

Transcatheter Tricuspid Valve Replacement: Overview of Current Clinical State

TCT 564: A New Perspective: Intracardiac Echocardiographic Guidance for the Implantation of a Left Atrial Appendage Occluder Device (Watchman) with a Leadless Pacemaker (Micra)

Good Early Outcomes With PCI in Complex Patients Unsuited to Surgery: OPTIMUM

TCT 563: Left Atrial Appendage Occlusion via Transhepatic Access in a Patient With Inferior Vena Cava Occlusion

CLASP

Triluminate

Who Is the Ideal Candidate for TEER? Clinical and Anatomical Considerations

TCT 540: LAVA-ECMO for Cardiogenic Shock and Acute Aortic Regurgitation as a Bridge to Valve-in-Valve TAVR and PCI

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Pascal EFS, EU Registry, and Compassionate Use Outcomes

Patient Preferences for Interventional versus Pharmaceutical Treatments Among U.S. Adults with Uncontrolled Hypertension

Triluminate Registry: Lessons Learned for TEER Trial Design

TCT 539: Use of Percutaneous Intra-aortic Mechanical Circulatory Support to Treat Acute Decompensated Heart Failure With Worsening Renal Function

Imaging Optimization and Algorithm for Procedural Success

Introduction to case: Zero contrast PCI in the RCA for an ACS patient with MVD

Dietary and Pharmacologic Approaches to Hypertension Management in 2021 – What’s New and What’s Changed

Standardized Nomenclature for Leaflet Anatomy and Utility for Pre-procedural TEER Planning

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content